This association was confirmed in breast and/or ovarian cancer families and cohorts with no known BRCA1 or BRCA2 mutations, leading to the proposition to include RAD51D and RAD51C to the list of genes screened for breast cancer predisposition [118,119,120]. This evidence concerns the gene RAD51D and ovarian carcinoma.